By otakuyassine3@gmail.com 
Integrated Investment Consultants LLC increased its stake in Colgate-Palmolive (NYSE:CL – Free Report) by 88.5% in the 4th quarter, HoldingsChannel.com reports. The fund owned 25,566 shares of the company’s stock after purchasing an additional 12,000 shares during the quarter. Integrated Investment Consultants LLC’s holdings in Colgate-Palmolive were worth $2,324,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds have also added to or reduced their stakes in the company. Envestnet Asset Management Inc. raised its stake in shares of Colgate-Palmolive by 16.2% in the second quarter. Envestnet Asset Management Inc. now owns 459,445 shares of the company’s stock worth $44,585,000 after purchasing an additional 64,123 shares during the last quarter. Edgestream Partners L.P. raised its position in Colgate-Palmolive by 13.9% in the 2nd quarter. Edgestream Partners L.P. now owns 19,864 shares of the company’s stock valued at $1,928,000 after buying an additional 2,423 shares during the last quarter. Mercer Global Advisors Inc. ADV boosted its holdings in Colgate-Palmolive by 2.0% during the 2nd quarter. Mercer Global Advisors Inc. ADV now owns 126,759 shares of the company’s stock worth $12,301,000 after acquiring an additional 2,541 shares during the last quarter. XTX Topco Ltd bought a new stake in shares of Colgate-Palmolive in the 2nd quarter worth $423,000. Finally, Brighton Jones LLC raised its holdings in shares of Colgate-Palmolive by 49.4% in the second quarter. Brighton Jones LLC now owns 10,308 shares of the company’s stock valued at $1,000,000 after purchasing an additional 3,410 shares during the last quarter. Institutional investors own 80.41% of the company’s stock.
Insider Buying and Selling
In other Colgate-Palmolive news, CFO Stanley J. Sutula III sold 45,410 shares of the firm’s stock in a transaction on Tuesday, November 5th. The shares were sold at an average price of $94.11, for a total value of $4,273,535.10. Following the sale, the chief financial officer now owns 36,726 shares of the company’s stock, valued at $3,456,283.86. This trade represents a 55.29 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 0.37% of the stock is owned by company insiders.
Colgate-Palmolive Stock Up 0.3 %
Shares of NYSE:CL opened at $88.79 on Friday. The company has a market cap of $72.55 billion, a price-to-earnings ratio of 25.44, a PEG ratio of 3.01 and a beta of 0.44. Colgate-Palmolive has a one year low of $79.69 and a one year high of $109.30. The firm has a fifty day moving average price of $92.27 and a two-hundred day moving average price of $97.78. The company has a debt-to-equity ratio of 9.46, a current ratio of 1.04 and a quick ratio of 0.68.
Colgate-Palmolive Dividend Announcement
The business also recently announced a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Tuesday, January 21st will be given a dividend of $0.50 per share. The ex-dividend date is Tuesday, January 21st. This represents a $2.00 annualized dividend and a yield of 2.25%. Colgate-Palmolive’s payout ratio is presently 57.31%.
Analyst Upgrades and Downgrades
Several research analysts recently weighed in on the stock. UBS Group cut their price target on shares of Colgate-Palmolive from $112.00 to $104.00 and set a “buy” rating on the stock in a report on Thursday. Barclays decreased their price target on Colgate-Palmolive from $96.00 to $83.00 and set an “equal weight” rating for the company in a research report on Friday. TD Cowen dropped their target price on shares of Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating on the stock in a research note on Wednesday, January 8th. Stifel Nicolaus decreased their target price on Colgate-Palmolive from $101.00 to $95.00 and set a “hold” rating for the company in a research report on Friday. Finally, Wells Fargo & Company dropped their price target on Colgate-Palmolive from $92.00 to $83.00 and set an “underweight” rating on the stock in a research report on Tuesday, January 7th. One research analyst has rated the stock with a sell rating, ten have given a hold rating and twelve have given a buy rating to the stock. According to data from MarketBeat.com, Colgate-Palmolive presently has a consensus rating of “Hold” and a consensus target price of $101.11.
Get Our Latest Analysis on Colgate-Palmolive
About Colgate-Palmolive
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
Featured Articles
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL – Free Report).
Receive News & Ratings for Colgate-Palmolive Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Colgate-Palmolive and related companies with MarketBeat.com’s FREE daily email newsletter.